Positive cross-match living donor kidney transplantation: Longer-term outcomes

American Journal of Transplantation

Volumn 9, Issue 3, 2009, Pages 536-542

  Haririan, A ^a   Nogueira, J ^a   Kukuruga, D ^b   Schweitzer, E ^a   Hess, J ^a   Gurk Turner, C ^b   Jacobs, S ^b   Drachenberg, C ^a   Bartlett, S ^b   Cooper, M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Desensitzation; Flow cytometry cross match; Intravenous immunoglobulin; Kidney transplantation; Plasma exchange; Positive cross match

Indexed keywords

BASILIXIMAB; CREATININE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PENTAGLOBULIN; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNITY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; CREATINE; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; TIME FACTORS; TREATMENT OUTCOME;

EID: 60649090478     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02524.x     Document Type: Article

References (34)

1. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966 2 : 662 665.
2. Williams GM, Hume DM, Hudson RP Jr., Morris PJ, Kano K, Milgrom F. "Hyperacute" renal-homograft rejection in man. N Engl J Med 1968 279 : 611 618.
3. Amos DB, Bashir H, Boyle W, MacQueen M, Tiilikainen A. A simple micro cytotoxicity test. Transplantation 1969 7 : 220 223.
4. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964 204 : 998 1000.
5. Scientific Registry of Transplant Recipients. 2007. 12-11-2007.
6. Kahn JP, Delmonico FL. The consequences of public policy to buy and sell organs for transplantation. Am J Transplant 2004 4 : 178 180.
7. Delmonico FL, Morrissey PE, Lipkowitz GS et al. Donor kidney exchanges. Am J Transplant 2004 4 : 1628 1634.
8. Montgomery RA, Zachary AA, Ratner LE et al. Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 2005 294 : 1655 1663.
9. Schweitzer EJ, Wilson JS, Fernandez-Vina M et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000 70 : 1531 1536.
10. Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000 70 : 887 895.
11. Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive cross-match in living-donor kidney transplantation. Am J Transplant 2003 3 : 1017 1023.
12. Jordan SC, Vo A, Bunnapradist S et al. Intravenous immune globulin treatment inhibits cross-match positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003 76 : 631 636.
13. Jacobs SC, Cho E, Dunkin BJ et al. Laparoscopic live donor nephrectomy: The University of Maryland 3-year experience. J Urol 2000 164 : 1494 1499.
14. Cook DJ, Terasaki PI, Iwaki Y et al. The flow cytometry cross-match in kidney transplantation. Clin Transpl 1987 1 : 409 414.
15. Fuller TC, Phelan D, Gebel HM, Rodey GE. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation 1982 34 : 24 29.
16. Kerman RH, Kimball PM, Van Buren CT et al. AHG and DTE/AHG procedure identification of cross-match-appropriate donor-recipient pairings that result in improved graft survival. Transplantation 1991 51 : 316 320.
17. Pei R, Lee J, Chen T, Rojo S, Terasaki PI. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999 60 : 1293 1302.
18. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003 75 : 43 49.
19. Scornik JC, Brunson ME, Schaub B, Howard RJ, Pfaff WW. The cross-match in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity. Transplantation 1994 57 : 621 625.
20. van Rood JJ, van LA, Ploem JS. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature 1976 262 : 795 797.
21. Kasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000 11 (Suppl 15 S1 86.
22. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
23. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
24. Sonnenday CJ, Ratner LE, Zachary AA et al. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant Proc 2002 34 : 1614 1616.
25. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006 6 : 346 351.
26. OPTN. 2008. Available from : http://www.optn.org/latestData/rptStart.asp. Accessed April 26, 2008.
27. OPTN. 2008. Available from : http://www.optn.org/AR2006/chapter-iv-AR-cd. htm. Accessed April 26, 2008.
28. Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific cross-match: A single center's perspective. Pediatr Transplant 2004 8 : 535 542.
29. Higgins R, Hathaway M, Lowe D et al. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007 84 : 876 884.
30. West-Thielke P, Herren H, Thielke J et al. Results of positive cross-match transplantation in African American renal transplant recipients. Am J Transplant 2008 8 : 348 354.
31. Higgins RM, Bevan DJ, Carey BS et al. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. Lancet 1996 348 : 1208 1211.
32. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002 2 : 758 760.
33. Jordan SC, Tyan D, Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial. J Am Soc Nephrol 2004 15 : 3256 3262.
34. Vo AA, Wechsler EA, Wang J et al. Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab. Am J Transplant 2008 8 : 144 149.